Table 4.
Association of Tea Content in Daily Consumption of Oil Tea with Obesity and Dyslipidemia
| Obesity OR (95% CI) | Abdominal Obesity OR (95% CI) | High TC OR (95% CI) | High TG OR (95% CI) | High LDL-C OR (95% CI) | Low HDL-C OR (95% CI) | |
|---|---|---|---|---|---|---|
| Overall | ||||||
| Non-drink oil tea (n=92) | 1 | 1 | 1 | 1 | 1 | 1 |
| Q1 (n= 479) | 0.864 (0.375–1.989) | 0.633 (0.389–1.030) | 1.001 (0.569–1.762) | 1.302 (0.643–2.638) | 1.348 (0.716–2.541) | 0.176 (0.034–0.924) |
| Q2 (n= 476) | 1.053 (0.462–2.404) | 0.647 (0.397–1.054) | 1.200 (0.686–2.101) | 1.255 (0.620–2.544) | 1.752 (0.936–3.278) | 0.171 (0.032–0.915) |
| Q3 (n= 477) | 1.112 (0.488–2.533) | 0.677 (0.415–1.105) | 1.129 (0.644–1.980) | 1.153 (0.567–2.345) | 1.742 (0.930–3.262) | 0.074 (0.010–0.549) |
| Q4 (n= 477) | 0.765 (0.327–1.791) | 0.537 (0.327–0.881) | 1.383 (0.792–2.416) | 1.318 (0.650–2.672) | 1.611 (0.860–3.017) | 0.073 (0.010–0.537) |
| P for trend | 0.745 | 0.094 | 0.056 | 0.814 | 0.129 | 0.025 |
| Male | ||||||
| Non-drink oil tea (n= 40) | 1 | 1 | 1 | 1 | 1 | 1 |
| Q1 (n= 177) | 1.755 (0.440–7.009) | 1.248 (0.486–3.205) | 1.520 (0.567–4.075) | 1.278 (0.438–3.728) | 1.032 (0.423–2.519) | 0.245 (0.014–4.369) |
| Q2 (n= 179) | 1.055 (0.254–4.381) | 0.769 (0.291–2.035) | 1.650 (0.617–4.412) | 0.916 (0.309–2.717) | 1.267 (0.522–3.075) | 0.322 (0.019–5.594) |
| Q3 (n= 177) | 0.869 (0.203–3.719) | 1.002 (0.384–2.619) | 2.213 (0.833–5.882) | 1.054 (0.356–3.122) | 1.324 (0.545–3.214) | 0.187 (0.009–3.790) |
| Q4 (n= 177) | 0.933 (0.219–3.979) | 0.975 (0.373–2.543) | 2.185 (0.824–5.793) | 1.145 (0.386–3.398) | 1.102 (0.453–2.679) | – |
| P for trend | 0.177 | 0.627 | 0.035 | 0.913 | 0.682 | 0.123 |
| Female | ||||||
| Non-drink oil tea (n= 52) | 1 | 1 | 1 | 1 | 1 | 1 |
| Q1 (n= 300) | 0.633 (0.220–1.819) | 0.523 (0.284–0.961) | 0.733 (0.359–1.496) | 1.610 (0.591–4.386) | 1.729 (0.676–4.423) | 0.096 (0.009–0.980) |
| Q2 (n= 300) | 0.639 (0.221–1.845) | 0.488 (0.265–0.899) | 0.947 (0.469–1.913) | 1.231 (0.448–3.388) | 2.760 (1.096–6.950) | 0.078 (0.006–0.961) |
| Q3 (n= 302) | 0.897 (0.319–2.524) | 0.530 (0.288–0.976) | 0.698 (0.342–1.425) | 1.511 (0.553–4.126) | 2.471 (0.976–6.256) | – |
| Q4 (n= 297) | 0.779 (0.273–2.225) | 0.413 (0.223–0.764) | 1.062 (0.526–2.147) | 1.581 (0.580–4.307) | 2.377 (0.939–6.017) | 0.120 (0.011–1.285) |
| P for trend | 0.561 | 0.044 | 0.34 | 0.597 | 0.075 | 0.218 |
Notes: Adjusted for age, and/or gender, ethnicity, education level, smoking, drinking, daily energy intake, daily protein intake, daily fat intake, daily carbohydrate intake, daily cholesterol intake, physical activity at work, walking time, systolic blood pressure, diastolic blood pressure, glucose and lipid-lowering drugs. – The prevalence of low HDL-C was 0. Bold type indicates statistical significance (P < 0.05).
Abbreviations: TC, total cholesterol; TG, triglycerides; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol.